Results 101 to 110 of about 48,810 (253)

Clinical staging of malignant pleural mesothelioma: current perspectives

open access: yes, 2017
Maria Bonomi,1 Costantino De Filippis,2 Egesta Lopci,3 Letizia Gianoncelli,1 Giovanna Rizzardi,4 Eleonora Cerchiaro,1 Luigi Bortolotti,4 Alessandro Zanello,2 Giovanni Luca Ceresoli1 1Department of Oncology, Thoracic and GU Oncology Unit, 2Department of ...
Bortolotti L   +8 more
core  

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate

open access: yesHistopathology, EarlyView.
FOXA1 is a highly sensitive diagnostic marker for prostate cancer. Besides prostatic adenocarcinoma, it is also expressed in 57%–80% of metastatic or primary prostatic small cell carcinomas, which lose traditional prostatic markers including NKX3.1. Although it is less specific than NKX3.1, it can serve as a valuable adjunct for confirming prostatic ...
Jianping Zhao   +11 more
wiley   +1 more source

Modern management of malignant pleural mesothelioma

open access: yes, 2016
Shivani C Patel,1 Jonathan E Dowell1,2 1Division of Hematology and Oncology, University of Texas Southwestern, 2Section of Hematology and Oncology, Veterans Affairs North Texas Healthcare System, Dallas, TX, USA Abstract: Malignant pleural mesothelioma (
Dowell JE, Patel SC
core  

Malignant Pleural Mesothelioma [PDF]

open access: yesMayo Clinic Proceedings, 2016
Melanie C, Bois   +2 more
openaire   +5 more sources

Malignant paratesticular mesothelioma

open access: yesAutopsy and Case Reports, 2014
Mesothelioma of the tunica vaginalis testis (MTVT) is a rare tumor that usually affects patients after the sixth decade of life. Exposure to asbestos is a known risk factor. Enlargement of the scrotal volume is the most common initial clinical manifestation, and about 15% of cases present metastasis at diagnosis.
Leonardo Gomes da Fonseca   +5 more
openaire   +3 more sources

Erased by law: Kinship, care, and bureaucratic exclusion at the end of life in South Korea

open access: yesMedical Anthropology Quarterly, EarlyView.
Abstract This article examines how institutional frameworks in South Korea erase nonlegal caregiving relationships within hospice care environments. Drawing on seven months of ethnographic fieldwork, the study delineates how patients are categorized as “unclaimed” despite the presence of long‐term companions or cohabitants who provide intimate end‐of ...
Seok Joo Youn
wiley   +1 more source

ADENOSINE RECEPTORS IN RESPIRATORY DISORDERS AS CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND MALIGNANT PLEURAL MESOTHELIOMA

open access: yes, 2012
Adenosine is a purine nucleoside that is commonly expressed in the body and involved in a wide range of physiological processes. The effects of adenosine are mediated through specific G-protein coupled cell surface receptors, named A1, A2A, A2B and A3 ...
Targa, Martina
core  

A Quarter Century of EHD Protein Research: From Endosomal Recycling to Ciliopathies

open access: yesTraffic, Volume 27, Issue 3, September 2026.
Human EHD protein subcellular localization. ABSTRACT Eps15 homology domain‐containing proteins comprise a conserved family of membrane‐remodeling ATPases that regulate endocytic trafficking, membrane fission, receptor recycling, primary ciliogenesis and membrane dynamics across eukaryotes. Since the initial identification of EHD1 and its Caenorhabditis
Devin Frisby   +3 more
wiley   +1 more source

Malignant Mesothelioma Presenting as a Gradually Enlarging Pneumothorax

open access: yesCase Reports in Pulmonology, 2013
Malignant mesothelioma is an extremely aggressive tumor arising from the pleura with median survival of approximately 9–12 months. It can rarely present as a spontaneous pneumothorax. Less than 35 cases of malignant mesothelioma presenting as spontaneous
Ashish Prasad, Diana Olsen, P. S. Sriram
doaj   +1 more source

TCF/LEF family transcription factors: Molecular landscape and prognostic scoring in pan‐cancer

open access: yesClinical and Translational Discovery, Volume 6, Issue 4, August 2026.
This study provides a comprehensive molecular landscape of TCF/LEF family transcription factors across 33 cancer types. We developed a TCF/LEF‐based prognostic score that correlates with immune infiltration, metabolic reprogramming and drug sensitivity, offering a robust transcriptomic signature for predicting patient survival and therapeutic response.
Zhengjun Yang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy